How long does CBD take to take effect?

A systematic review published in Cannabis and Cannabinoid Research (Millar et al., 2018, international study) brought together some twenty clinical trials. The conclusions retained: peak plasma concentration (Tmax) ranges from 1 to 4 hours for oral CBD and drops to 15-30 minutes for sublingual and inhaled administration. The same review notes that the oral bioavailability of CBD is low (6 to 19 %), which partly explains the variability felt from one person to another.

These data come from international studies and do not carry the weight of an official French recommendation. To date, no French authority — ANSM, HAS, ANSES — has validated a time to effect or a dosage for wellbeing CBD.

CBD products available in France use three broad routes, whose pharmacokinetic profiles differ.

• Sublingual (oil under the tongue, held for 60 to 90 seconds): 15 to 45 minutes for the first sensations, according to the pharmacokinetic data reported.
• Oral (capsules, infusion, food): 1 to 2 hours, with an effect potentially reduced by first-pass hepatic metabolism.
• Vaporisation (e-liquid or flower from a herbalist): a few minutes, with a shorter duration.

CBD food products (gummies, bud-based infusions, drinks) have, however, been subject since 15 May 2026 to withdrawal by the DGAL in the absence of Novel Food authorisation, according to the EFSA and the DGAL. Sublingual oils reclassified as topical cosmetics and vaporised flowers remain the routes most present on the market.

Several wellbeing brands recommend an assessment period of four to six weeks before judging the usefulness of a CBD product. This period is not an official standard; it reflects the time generally needed to observe an effect on subjective indicators (quality of rest, sense of relaxation) within a stable routine.

According to the IFOP 2022 survey of French consumers, the most frequently reported uses concern a relaxation approach and sleep quality. Under French law these motives do not constitute validated claims, and no CBD product sold in a shop may display a therapeutic effect, according to the position of MILDECA.

Several factors alter how the effects are perceived:

• Body weight and lipid composition: CBD is lipophilic, so its distribution depends on fat mass.
• Hepatic metabolism (CYP3A4, CYP2C19): drug interactions are possible, which is why medical advice is warranted if you are on treatment.
• Time of intake and nutritional state: taking it with a meal rich in lipids appreciably increases oral bioavailability, according to the pharmacokinetic data from Millar et al.
• Regularity: occasional use does not produce the same experience as use settled over several weeks.

Since the Conseil d'État ruling of 29 December 2022 (no. 444887), flowers, leaves and derived products containing ≤ 0.30 % THC in the finished product may be sold in France. Synthetic and semi-synthetic cannabinoids (HHC, H4CBD, THCP, HHCO) were classified as narcotics by the ANSM in June 2023 and then June 2024, and their sale is prohibited.

On 9 February 2026 the EFSA published a provisionally safe daily dose of 0.0275 mg/kg/day (around 2 mg/day for a 70 kg adult) for ingested CBD. That figure calls for caution over the strong dosages sold as "supplements".

To assess whether a product suits you, a few practical markers:

• Choose one route of administration and stick to it during the assessment phase.
• Take the product at stable times (for example in the evening around 21:00).
• Keep a brief journal (mood, quality of rest, level of tension) over four to six weeks.
• Limit external variables (coffee, screens, alcohol consumption) that could skew how you feel.

This is a matter of a personal wellbeing routine, not a medical protocol.

• Sublingual route: 15-45 minutes for the first reported sensations
• Oral route: 1-2 hours, low bioavailability
• Vaporisation: a few minutes, shorter duration
• Recommended assessment period: 4 to 6 weeks at a stable dose
• Cannabinoids prohibited since 2024: HHC, H4CBD, THCP, HHCO
• EFSA: provisional daily dose of 2 mg/day for ingested CBD

Why do people around me feel an immediate effect and I don't?

Variability between individuals is documented: metabolism, body mass, route of administration and nutritional state all alter the kinetics. No French data allows anyone to promise a uniform time to effect.

Should CBD be taken on an empty stomach or with a meal?

Taking it with a meal rich in lipids increases oral bioavailability according to international pharmacokinetic studies. The sublingual route is less sensitive to this effect.

How many weeks before deciding a product does not suit me?

Wellbeing brands generally suggest 4 to 6 weeks at a stable dose and time. That is a practical marker, not an official health standard.

Can CBD interact with my medication?

Yes, CBD is metabolised by the cytochromes CYP3A4 and CYP2C19, which are shared with many medicines. A medical consultation is essential if you are on treatment.

Why are some CBD food products no longer on the shelves?

Since 15 May 2026 the DGAL has been applying the Novel Food regulation strictly: CBD food products without a validated dossier are withdrawn from the market.

CBD is not a medicine. If a symptom persists (sleep, pain, anxiety), consult a health professional.

To explore our wellbeing selection, [see our catalogue](/categorie-produit).

• Conseil d'État, 29 Dec. 2022, no. 444887 (flowers/leaves) — primary
• EFSA Journal 2026 — Update statement CBD novel food — primary
• ANSES — Press release 19 June 2025 on the reprotoxic classification of CBD (PDF) — primary